Financials
- Market Capitalization 49.03 M
- Employee 58
- Founded 2005
- CEO N/A
- Website www.atyrpharma.com
- Headquarter Delaware, United States
- FIGI BBG001J2P692
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.98
売上高対価格比率
383.25
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4303 | MGX Metagenomi Therapeutics, Inc. - Common Stock | 1.32 USD | +3.94% | +5.60% | +8.20% | -8.33% | 49.69 M USD | ||
| 4306 | INMB INmune Bio Inc. - Common stock | 1.86 USD | -4.12% | +11.38% | +47.62% | -12.68% | 49.45 M USD | ||
| 4349 | HYPD Hyperion DeFi, Inc. - Common Stock | 2.97 USD | -3.88% | -7.48% | +3.12% | -75.25% | 45.02 M USD | ||
| 4374 | PDSB PDS Biotechnology Corporation - Common Stock | 0.75 USD | -2.60% | -11.76% | -30.56% | -38.52% | 41.86 M USD |